Impact of cognitive behavioral therapy for insomnia disorder on sleep and comorbid symptoms in military personnel: a randomized clinical trial

Taylor, Daniel J.; Peterson, Alan L.; Pruiksma, Kristi E.; Hale, Willie J.; Young‐McCaughan, Stacey; Wilkerson, Allison K.; Nicholson, Karin L.; Litz, Brett T.; Dondanville, Katherine A.; Roache, John D.; Borah, Elisa V.; Brundige, Antoinette; Mintz, Jim

doi:10.1093/sleep/zsy069

Cited by 42 publications

(31 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The two general approaches are either to treat the already established unhealthy behaviors with therapy, education, and/or pharmacological programs, or to develop a proactive approach to prevent them from occurring in the first place. Treatments to address tobacco use and insomnia, for example, have had measureable success in modifying behaviors [39][40][41][42][43]. However, a proactive approach would be more efficient and potentially impactful [44][45][46].…”

Section: Plos Onementioning

confidence: 99%

Mental health, physical health, and health-related behaviors of U.S. Army Special Forces

et al. 2020

View full text Add to dashboard Cite

Objectives To prospectively examine the health and health-related behaviors of Army Special Forces personnel in comparison with two distinct, but functionally similar Army groups. Methods Special Forces, Ranger Qualified, and General Purposes Forces enrolled in the Millennium Cohort Study were identified using data from the Defense Manpower Data Center. Using prospective survey data (2001-2014), we estimated the association of Army specialization with mental health, social support, physical health, and health-related behaviors with multivariable regression models. Results Among the 5,392 eligible participants (84.4% General Purposes Forces, 10.0% Special Forces, 5.6% Ranger Qualified), Special Forces personnel reported the lowest prevalence of mental disorders, physical health problems, and unhealthy behaviors. In the multivariable models, Special Forces personnel were less likely to report mental health problems, multiple somatic symptoms, and unhealthy behaviors compared with General Purpose Forces infantrymen (odds ratios [OR]: 0.20-0.54, p-values < .01). Overall, Special Forces personnel were similar in terms of mental and physical health compared with Ranger Qualified infantrymen, but were less likely to sleep < 5 hours/night (OR: 0.60, 95% confidence intervals: 0.40, 0.92) and have 5 or more multiple somatic symptoms (OR: 0.69, 95% CI: 0.49, 0.98). Both Special Forces personnel and Ranger Qualified infantrymen engaged in more healthy behaviors compared with General Purpose Forces infantrymen (OR: 2.57-6.22, p-PLOS ONE

show abstract

Section: Plos Onementioning

confidence: 99%

Mental health, physical health, and health-related behaviors of U.S. Army Special Forces

et al. 2020

View full text Add to dashboard Cite

show abstract

“…[30][31][32] Improving sleep quality has been associated with a clinically relevant reduction in the severity and impact of PTSD symptomology, thus highlighting the importance of specifically targeting sleep as part of a multi-faceted approach for PTSD treatment. [33][34][35] Despite these findings, and high prevalence, a specific mechanistic role of sleep in PTSD, as well as the reciprocal nature of the relationship between SDs and PTSD, remains to be established. 25 Furthermore, subjective and objective sleep measures have yielded conflicting reports on the number of awakenings and sleep duration in PTSD, depending on the comparative population used.…”

Section: Introductionmentioning

confidence: 99%

<p>Sleep, a Governor of Morbidity in PTSD: A Systematic Review of Biological Markers in PTSD-Related Sleep Disturbances</p>

Maguire¹,

Ruddock

Milanak

et al. 2020

NSS

View full text Add to dashboard Cite

Background: Sleep disturbances (SD) are the most impactful and commonly reported symptoms in post-traumatic stress disorder (PTSD). Yet, they are often resistant to primary PTSD therapies. Research has identified two distinct SDs highly prevalent in PTSD; insomnia and nightmares. Those who report SDs prior to a traumatic event are at greater risk for developing PTSD; highlighting that sleep potentially plays a role in PTSD's pathology. To further understand the pathobiological mechanisms that lead to the development of PTSD, it is first imperative to understand the interplay which exists between sleep and PTSD on a biological level. The aim of this systematic review is to determine if biological or physiological markers are related to SD in PTSD. Methods: A systematic literature search was conducted on the electronic databases; Medline, Embase, AMED and PsycINFO, using Medical Subject Headings and associated keywords. Results: Sixteen studies were included in the final analyses. Physiological makers of autonomic function, and biochemical markers of HPA-axis activity; inflammatory processes; and trophic factor regulation were related to the severity of SDs in PTSD. Conclusion: These findings add to the growing literature base supporting a central focus on sleep in research aiming to define the pathophysiological processes which result in PTSD, as well as emphasising the importance of specifically targeting sleep as part of a successful PTSD intervention strategy. Resolving SDs will not only reduce PTSD symptom severity and improve quality of life but will also reduce all-cause mortality, hospital admissions and lifetime healthcare costs for those with PTSD. Limitations of the current literature are discussed, and key recommendations future research must adhere to are made within.

show abstract

“…They can effectively improve sleep and have almost no side effects. [ 14 15 ] However, its clinical practice is limited by the lack of well-trained therapists and poor patient compliance. [ 16 17 ] Clinical drugs mainly include benzodiazepines, non-benzodiazepines, melatonin receptor agonists, orexin receptor antagonists, and antidepressants with hypnotic effects.…”

Section: Introductionmentioning

confidence: 99%

Effectiveness and safety of electroacupuncture for insomnia

et al. 2020

View full text Add to dashboard Cite

Background: Insomnia is a common disease characterized by difficulty falling and/or staying asleep, and accompanied by irritability or fatigue during wakefulness. It is widely reported that insomnia is one of the most extensive mental disorders which the incidence rate is estimated to be about 10%. Insomnia can have serious influences on patients health and quality of life. Electro acupuncture (EA) is reported to be efficacious and widely used for the treatment of insomnia in China. This overview aims to summarize the available evidence from current systematic reviews for the efficacy of electroacupuncture therapy for insomnia. Methods: We will make a comprehensive retrieval in 7 databases as following: Embase; Cochrane Library; Pubmed; Chinese databases SinoMed (previously called the Chinese Biomedical Database); Chinese National Knowledge Infrastructure (CNKI); Chinese Scientific Journals Database (VIP); Wanfang Data (WF). The time is limited from the construction of the library to August 2020. We will use the Assessment of Multiple Systematic Reviews-2 (AMSTAR-2) tool to evaluate methodological quality. Preferred Reporting Items for Systematic Reviews and Meta-analysis Protocols (PRISMA-P) will be used in the report checklist to assess the quality of reports in the study. The Grading of the Classification of Recommendations, Evaluation, Development and Evaluation (GRADE) will be used to evaluate the included SRs and meta-analysis. Our reviewers will conduct systematic reviews, qualification evaluation, data extraction, methodological quality and evidence quality screening in pairs. The outcomes of interest include: The Pittsburgh Sleep Quality Index (PSQI), The Insomnia Severity Index (ISI), Athens Insomnia Scale, Sleep parameters measured by either subjective or objective approaches, such as actigraphy, polysomnogram, and electroencephalogram. Or any other scale used to assess the level of illness. The evidence will be synthesized where appropriate based on patient subgroups and outcomes. Results: The results will be published in a peer-reviewed journal. Trial registration number: INPLASY202080087. Conclusion: This overview will provide comprehensive evidence of EA for patients with insomnia.

show abstract

Impact of cognitive behavioral therapy for insomnia disorder on sleep and comorbid symptoms in military personnel: a randomized clinical trial

Cited by 42 publications

References 39 publications

Mental health, physical health, and health-related behaviors of U.S. Army Special Forces

Mental health, physical health, and health-related behaviors of U.S. Army Special Forces

<p>Sleep, a Governor of Morbidity in PTSD: A Systematic Review of Biological Markers in PTSD-Related Sleep Disturbances</p>

Effectiveness and safety of electroacupuncture for insomnia

Contact Info

Product

Resources

About